Shares of Vertex Pharmaceuticals Inc. VRTX shed 4.07% to $448.01 Tuesday, on what proved to be an all-around mixed trading ...

IIM Calcutta teams up with Ivey Publishing to share its collection of India-focused business case studies globally, offering ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first ...

A Relative Strength Rating upgrade for Vertex Pharmaceuticals shows improving technical performance. Will it continue?

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

With promising Phase 1 results in hand, Metsera hopes to develop a longer-lasting GLP-1 injection along with other types of ...